<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141393">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02105883</url>
  </required_header>
  <id_info>
    <org_study_id>MEB-2014</org_study_id>
    <nct_id>NCT02105883</nct_id>
  </id_info>
  <brief_title>The Effect of Identification Badge on Situation Awareness During High Fidelity Simulation</brief_title>
  <official_title>The Effect of Identification Badge on Situation Awareness During High Fidelity Simulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Montréal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre d'apprentissage des attitudes et des habiletés cliniques (CAAHC)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université de Montréal</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate if the use of identification badge (role and place)
      during high-fidelity simulation as an impact on situation awareness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-fidelity simulation is well recognized as an educational tool. Mr. Issenberg completed
      a review(2005) that determined features of high-fidelity simulation training that lead to
      effective learning. It this review, it is mentioned that the validity of the simulator
      (realism) is essential to help learners to increase their skills and sharpen their
      responses. It is essential to get and maintain engagement during high-fidelity simulation
      and it pass by an increase in realism and situation awareness. The purpose of this study is
      to evaluate if the use of identification badge (physical and conceptual realism) during
      high-fidelity simulation as an impact on situation awareness and engagement.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>Situation awareness</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjects answer a 4 questions survey on situation awareness with 7 answers choices (1-strongly disagree... 7-strongly agree)
I know where I was in the beginning of the scenario
I know where I was during the scenario
I know the role of each participant in the beginning of the scenario
I Know the role of each participant during the scenario</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject's engagement in high-fidelity simulation</measure>
    <time_frame>2 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subject answer a 2 questions survey on engagement with a 7 answers choices (1- strongly disagree...7-strongly agree)
I felt emotionally concerned during the scenario
The scenario was enough realistic to get engaged in the clinical situation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Patient Simulation</condition>
  <condition>Awareness</condition>
  <condition>Reality Testing</condition>
  <condition>Residency</condition>
  <arm_group>
    <arm_group_label>Scenario C (control)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no badge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Scenario B (badge)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use of Identification badge during scenarios (roles and places)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Use of identification badge during scenarios</intervention_name>
    <arm_group_label>Scenario B (badge)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  anesthesiology residents (university of montreal) who participate to simulation
             course on crisis resources management

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Issam Tanoubi, MD</last_name>
    <role>Study Director</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Eve Belanger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Issam Tanoubi, MD</last_name>
    <phone>514 252 3426</phone>
    <email>i.tanoubi@umontreal.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Eve Belanger, MD</last_name>
    <phone>514 622 9912</phone>
    <email>marie-eve.belanger.7@umontreal.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CAAHC</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T 1J4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Issam Tanoubi, MD</last_name>
      <phone>514 252 3426</phone>
      <email>i.tanoubi@umontreal.ca</email>
    </contact>
    <contact_backup>
      <last_name>Marie-Eve Belanger, MD</last_name>
      <phone>514 622 9912</phone>
      <email>marie-eve.belanger.7@umontreal.ca</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 21, 2014</lastchanged_date>
  <firstreceived_date>March 25, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Université de Montréal</investigator_affiliation>
    <investigator_full_name>Issam Tanoubi</investigator_full_name>
    <investigator_title>Université de Montréal</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
